• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Association between time of heparin exposure and platelets decline in patients with heparin induced thrombocytopenia.

作者信息

Moghaddam Omid Moradi, Ramsheh Zohreh Heydari, Sedighi Mohsen, Amanollahi Alireza, Lahiji Mohammad Niakan

机构信息

Trauma and Injury Research Center, Iran University of Medical Sciences, Tehran, Iran; School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

出版信息

Hematol Transfus Cell Ther. 2024 Oct-Dec;46(4):572-574. doi: 10.1016/j.htct.2023.11.009. Epub 2024 Jan 19.

DOI:10.1016/j.htct.2023.11.009
PMID:38307828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11451345/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1cd/11451345/fba5c97e2499/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1cd/11451345/fba5c97e2499/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1cd/11451345/fba5c97e2499/gr1.jpg

相似文献

1
Association between time of heparin exposure and platelets decline in patients with heparin induced thrombocytopenia.肝素诱导的血小板减少症患者中肝素暴露时间与血小板减少之间的关联。
Hematol Transfus Cell Ther. 2024 Oct-Dec;46(4):572-574. doi: 10.1016/j.htct.2023.11.009. Epub 2024 Jan 19.
2
TULA-2 (T-Cell Ubiquitin Ligand-2) Inhibits the Platelet Fc Receptor for IgG IIA (FcγRIIA) Signaling Pathway and Heparin-Induced Thrombocytopenia in Mice.TULA-2（T细胞泛素配体-2）抑制小鼠IgG IIA血小板Fc受体（FcγRIIA）信号通路及肝素诱导的血小板减少症。
Arterioscler Thromb Vasc Biol. 2016 Dec;36(12):2315-2323. doi: 10.1161/ATVBAHA.116.307979. Epub 2016 Oct 20.
3
Identifying patients at high risk of heparin-induced thrombocytopenia-associated thrombosis with a platelet activation assay using flow cytometry.通过流式细胞术血小板活化试验识别肝素诱导的血小板减少症相关血栓形成的高危患者。
Thromb Haemost. 2017 Jan 5;117(1):127-138. doi: 10.1160/TH16-06-0482. Epub 2016 Oct 13.
4
Platelet aggregation studies for the diagnosis of heparin-induced thrombocytopenia.用于诊断肝素诱导的血小板减少症的血小板聚集研究。
Am J Clin Pathol. 1993 Mar;99(3):324-30. doi: 10.1093/ajcp/99.3.324.
5
Functional heterogeneity of antiheparin-platelet factor 4 antibodies: implications in the pathogenesis of the HIT syndrome.抗肝素-血小板因子4抗体的功能异质性：对肝素诱导的血小板减少症综合征发病机制的影响
Clin Appl Thromb Hemost. 1999 Oct;5 Suppl 1:S32-7. doi: 10.1177/10760296990050s107.
6
Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia.检测肝素诱导的血小板减少症时供体血小板变异性的决定因素。
J Lab Clin Med. 1992 Sep;120(3):371-9.
7
Determination of serotonin release from platelets by enzyme immunoassay in the diagnosis of heparin-induced thrombocytopenia.通过酶免疫测定法测定血小板中5-羟色胺释放用于肝素诱导的血小板减少症的诊断
Br J Haematol. 2000 Apr;109(1):182-6. doi: 10.1046/j.1365-2141.2000.01966.x.
8
The incidence of thrombocytopenia associated with continuous renal replacement therapy in critically ill patients.危重症患者连续性肾脏替代治疗相关血小板减少症的发生率。
Ren Fail. 2015 Aug;37(7):1232-6. doi: 10.3109/0886022X.2015.1057799. Epub 2015 Jun 25.
9
Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.膜表达的血小板因子 4 的生理变化：肝素诱导的血小板减少症的意义。
Thromb Res. 2010 Apr;125(4):e143-8. doi: 10.1016/j.thromres.2009.10.021.
10
Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets.肝素诱导的血小板减少症：肝素依赖性抗体与血小板相互作用的机制
Br J Haematol. 1989 Oct;73(2):235-40. doi: 10.1111/j.1365-2141.1989.tb00258.x.

本文引用的文献

1
Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis.4Ts 评分系统对肝素诱导的血小板减少症的预测价值：系统评价和荟萃分析。
Blood. 2012 Nov 15;120(20):4160-7. doi: 10.1182/blood-2012-07-443051. Epub 2012 Sep 18.
2
Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.肝素诱导的血小板减少症的治疗和预防：抗血栓治疗与血栓预防，第 9 版：美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e495S-e530S. doi: 10.1378/chest.11-2303.
3
How I treat heparin-induced thrombocytopenia.
我如何治疗肝素诱导的血小板减少症。
Blood. 2012 Mar 8;119(10):2209-18. doi: 10.1182/blood-2011-11-376293. Epub 2012 Jan 13.
4
How I diagnose and manage HIT.如何诊断和管理 HIT。
Hematology Am Soc Hematol Educ Program. 2011;2011:143-9. doi: 10.1182/asheducation-2011.1.143.
5
Contemporary standards for the diagnosis and treatment of heparin-induced thrombocytopenia (HIT).肝素诱导的血小板减少症（HIT）的当代诊断和治疗标准。
Surgery. 2008 Mar;143(3):305-12. doi: 10.1016/j.surg.2007.09.036. Epub 2007 Dec 21.
6
Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia.对用于诊断肝素诱导的血小板减少症的“4T”评分及肝素/血小板第4因子特异性颗粒凝胶免疫测定法的前瞻性评估。
J Thromb Haemost. 2007 Jul;5(7):1373-9. doi: 10.1111/j.1538-7836.2007.02524.x. Epub 2007 Mar 14.
7
Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia.肝素诱导的血小板减少症中的性别失衡与危险因素相互作用
Blood. 2006 Nov 1;108(9):2937-41. doi: 10.1182/blood-2005-11-012450. Epub 2006 Jul 20.
8
Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?针对导致肝素诱导的血小板减少症的抗体的实验室检测：我们需要多少类别？
J Lab Clin Med. 2005 Dec;146(6):341-6. doi: 10.1016/j.lab.2005.08.003.
9
Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin.接受磺达肝癸钠或依诺肝素抗血栓预防的骨科手术患者中的抗血小板因子4/肝素抗体
Blood. 2005 Dec 1;106(12):3791-6. doi: 10.1182/blood-2005-05-1938. Epub 2005 Aug 18.